Join Peter Grayson, MD, MSc, and I as we discuss a range of topics, including imaging in large-vessel vasculitis, doctors going into research, Twitter, rock ‘n’ roll and Disney World.

• Intro :10
• A bit about Peter Grayson :55
• Come see me in Phoenix in February 3:35
• The interview 4:07
  • How did you make it to the NIH? 4:27
  • Why do you think MDs aren’t going into research these days 6:45
  • Social media and major meetings 9:43
  • Tell us about the NIH rock ‘n’ roll band 11:10
  • What imaging modalities are most used for large-vessel vasculitis? 13:32
  • What is PET scan? 14:23
    • Do you think PET scanning is the best imaging modality? 15:29
    • What are the limitations to PET? 17:48
    • Does vessel size affect PET scanning? 20:01
    • Are these machines available in most hospitals? 21:12
    • Grayson’s secret sauce 22:27
    • How do glucocorticoids affect imaging? 23:19
    • Are you ever using PET as follow-up? 25:07
  • Do you have hope for any specific targets for Takayasu’s arteritis? 27:12
    • What drives the surgical intervention process for these patients? 28:23
    • Collateral artery formation 30:30
  • Where do you think Takayasu’s will be in 10 years? 31:35
• Thank you, Dr. Grayson 33:36

We’d love to hear from you! Send your comments/questions to [email protected]. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum

Disclosures: Brown and Grayson report no relevant financial disclosures.

Peter Grayson, MD, MSc, is head of the Vasculitis Translational Research Program at National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and associate director of the NIAMS Fellowship Program, Systemic Autoimmunity Branch.